Last reviewed · How we verify
Finasteride 0.25%
At a glance
| Generic name | Finasteride 0.25% |
|---|---|
| Also known as | P-3074 |
| Sponsor | Polichem S.A. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Nasopharyngitis
- Headache
- Pruritus
- Influenza
- Erythema
- Toothache
- Pyrexia
- Respiratory tract infection viral
- Diarrhoea
- Gastritis
- Gastroenteritis
- Urinary tract infection
Key clinical trials
- Various Procedural Treatment Options for Androgenetic Alopecia (PHASE2)
- A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA) (PHASE3)
- Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia (PHASE3)
- Photosensitization Study in Androgenetic Alopecia (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |